Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model

por Rauktys, Aubrey, Lee, Nancy, Lee, Laifong, Dabora, Sandra L
Publicado 2008

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

por Messina, Michael P, Rauktys, Aubrey, Lee, Laifong, Dabora, Sandra L
Publicado 2007

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

por Lee, Nancy, Woodrum, Chelsey L, Nobil, Alison M, Rauktys, Aubrey E, Messina, Michael P, Dabora, Sandra L
Publicado 2009